Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institute of Cancer Research, United Kingdom
With
Royal Marsden NHS Foundation Trust
Cambridge University Hospitals NHS Foundation Trust
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Two patient groups will be included:
1. IMPORT or FAST trial patients who received breast RT previously and have received four (or more) year follow-up assessment which found moderate or severe induration.
2. Patients who are (1) undergoing, or undergone recently, breast RT (general population) and have undergone a clinical assessment that found moderate or severe oedema, or (2) IMPORT HIGH patients who have received RT and have received one or two year follow-up which found moderate or severe oedema.
You may not be if
Patients with bi-lateral breast cancer.
Patients who have undergone surgery to the contralateral breast for either benign or malignant conditions.
Clareo Health | Quantification of Breast RadioTherapy Associated Late Toxicity Using Novel UltraSound Techniques
